http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1320757-B1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_aa5a9b8e5a82441348dda9d4f6372289 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-66 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-66 |
| filingDate | 2001-09-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2005-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_44d42b4b5ebee4049376861adf21ec78 |
| publicationDate | 2005-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-1320757-B1 |
| titleOfInvention | Method for diagnosing lactose intolerance and diagnosis kit for carrying out the method |
| abstract | The method for diagnosing lactose intolerance in patients by the oral administration of defined amounts of lactose, followed by assaying metabolites of lactose, is performed in a way where the lactose administered contains 99% <SUP>13</SUP>-labeled lactose, preferably from 5 to 30 mg, and after the administration of the <SUP>13</SUP>C-lactose, the content of <SUP>13</SUP>C-labeled lactose is determined in a serum sample taken at a defined time after the administration. A diagnostic kit for performing the method consists of a capsule with from 5 to 30 mg of 99% <SUP>13</SUP>C-labeled lactose, a patient instruction manual, a blood sampling device, sample containers for collecting the blood sample, and optionally a spatula and sample container for a stool specimen. |
| priorityDate | 2000-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 122.